Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Tomsic

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Clinical and Experimental Rheumatology|January 17, 2002
Is Sjögren's syndrome involved in the formation of localised nodular amyloidosis?S Praprotnik, M Tomsic, T Perkovic, et al.
Lupus|July 26, 2005
Azathioprine induced hepatic veno-occlusive disease in systemic lupus erythematosusS Praprotnik, A Hocevar, V Ferlan-Marolt, et al.
Clinical Rheumatology|May 1, 1995
Prevalence of autoimmune thyroid disease (AITD) in patients with mixed connective tissue disease (MCTD)M Tomsic, S Hojker, L Zaletel-Kragelj, et al.
Pflugers Archiv : European Journal of Physiology|September 27, 2000
Interleukin-6 (IL-6) and soluble receptors for interleukin-2 (sIL-2R) in the diagnosis of early severe infection in the critically ill newbornsM Tomsic Matić, M Derganc, B Wraber, et al.
Journal of Dental Research|January 26, 2006
Articaine is more effective than lidocaine or mepivacaine in rat sensory nerve conduction block in vitroI Potocnik, M Tomsic, J Sketelj, et al.
Clinical and Experimental Rheumatology|August 5, 2011
Endothelium-dependent and independent dilation capability of peripheral arteries in patients with systemic lupus erythematosus and antiphospholipid syndromeM Stalc, M Tomsic, M K Jezovnik, et al.
The Pharmacogenomics Journal|May 25, 2016
Clinical-pharmacogenetic predictive models for MTX discontinuation due to adverse events in rheumatoid arthritisB Jenko, L Lusa, M Tomsic, et al.
Annals of the New York Academy of Sciences|August 30, 2005
Avidity of anti-beta2-glycoprotein I and thrombosis or pregnancy loss in patients with antiphospholipid syndromeS Cucnik, B Bozic, T Kveder, et al.
Rheumatology (Oxford, England)|March 3, 2005
Ultrasonographic changes of major salivary glands in primary Sjogren's syndrome. Diagnostic value of a novel scoring systemA Hocevar, A Ambrozic, B Rozman, et al.
Annals of the Rheumatic Diseases|August 14, 2008
Could tumour necrosis factor blockers inhibit the progression of future structural damage in ankylosing spondylitis?N Gaspersic, I Sersa, V Jevtic, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Clinical and Experimental Rheumatology|January 17, 2002
Is Sjögren's syndrome involved in the formation of localised nodular amyloidosis?S Praprotnik, M Tomsic, T Perkovic, et al.
Lupus|July 26, 2005
Azathioprine induced hepatic veno-occlusive disease in systemic lupus erythematosusS Praprotnik, A Hocevar, V Ferlan-Marolt, et al.
Clinical Rheumatology|May 1, 1995
Prevalence of autoimmune thyroid disease (AITD) in patients with mixed connective tissue disease (MCTD)M Tomsic, S Hojker, L Zaletel-Kragelj, et al.
Pflugers Archiv : European Journal of Physiology|September 27, 2000
Interleukin-6 (IL-6) and soluble receptors for interleukin-2 (sIL-2R) in the diagnosis of early severe infection in the critically ill newbornsM Tomsic Matić, M Derganc, B Wraber, et al.
Journal of Dental Research|January 26, 2006
Articaine is more effective than lidocaine or mepivacaine in rat sensory nerve conduction block in vitroI Potocnik, M Tomsic, J Sketelj, et al.
Clinical and Experimental Rheumatology|August 5, 2011
Endothelium-dependent and independent dilation capability of peripheral arteries in patients with systemic lupus erythematosus and antiphospholipid syndromeM Stalc, M Tomsic, M K Jezovnik, et al.
The Pharmacogenomics Journal|May 25, 2016
Clinical-pharmacogenetic predictive models for MTX discontinuation due to adverse events in rheumatoid arthritisB Jenko, L Lusa, M Tomsic, et al.
Annals of the New York Academy of Sciences|August 30, 2005
Avidity of anti-beta2-glycoprotein I and thrombosis or pregnancy loss in patients with antiphospholipid syndromeS Cucnik, B Bozic, T Kveder, et al.
Rheumatology (Oxford, England)|March 3, 2005
Ultrasonographic changes of major salivary glands in primary Sjogren's syndrome. Diagnostic value of a novel scoring systemA Hocevar, A Ambrozic, B Rozman, et al.
Annals of the Rheumatic Diseases|August 14, 2008
Could tumour necrosis factor blockers inhibit the progression of future structural damage in ankylosing spondylitis?N Gaspersic, I Sersa, V Jevtic, et al.
Pageof 5